Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/1330318

Download in:

View as

General Info

PMID
1330318